PAB 0.00% 0.3¢ patrys limited

Any potential partners can see we are funded to go to trial.HiI...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 16,462 Posts.
    lightbulb Created with Sketch. 774
    Any potential partners can see we are funded to go to trial.

    Hi

    I am pleased to advise that Patrys wholly-owned subsidiary Nucleus Therapeutics Pty Ltd has received a $3.35 million R&D Tax Incentive Refund for the 2021/2022 financial year.

    With this rebate and our current cash balance, our Company can confidently advance our first deoxymabs into the clinic by the end of 2023.

    We are grateful for the support of the Australian Government through this initiative, which motivates investment in Australian-led innovation.

    If you have any questions, please contact our team via the details below.

    Last edited by malmanu: 30/01/23
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $6.172M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $10.97K 3.626M

Buyers (Bids)

No. Vol. Price($)
41 31554019 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 27089307 15
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.